We are live on ! Find out more
BKYI

BIO-key International

0 hedge funds and large institutions have $0 invested in BIO-key International in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.39% less ownership

Funds ownership: 0.39%0% (-0.39%)

100% less funds holding

Funds holding: 100 (-10)

100% less capital invested

Capital invested by funds: $227K → $0 (-$227K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
Holders Change
-10
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
1
Geode Capital Management
Massachusetts
-$157K -29,543 Closed
Citigroup
2
Citigroup
New York
-$26.7K -5,035 Closed
Vanguard Capital Management
3
Vanguard Capital Management
Pennsylvania
-$18.5K -3,485 Closed
VF
4
Virtu Financial
New York
-$11K -2,071 Closed
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
-$9.11K -1,719 Closed
UBS Group
6
UBS Group
Switzerland
-$2.95K -556 Closed
Morgan Stanley
7
Morgan Stanley
New York
-$1.06K -200 Closed
TRCT
8
Tower Research Capital (TRC)
New York
-$929 -175 Closed
SS
9
SBI Securities
Japan
-$159 -30 Closed
HI
10
Harbour Investments
Wisconsin
-$3 -1 Closed

BKYI Hedge Fund Activity: Q2 2026 in Review

0 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q2 2026, worth a combined $0 — down 100% from $227K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of BKYI and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Geode Capital Management, exiting entirely with an estimated $157K sold.

  • 0 institutional investors held BIO-key International (BKYI) as of Q2 2026, down from 10 in Q1 2026.
  • Funds reported $0 of BIO-key International stock for Q2 2026, down 100% quarter-over-quarter.
  • 0 funds opened new BIO-key International positions in Q2 2026 and 10 closed out, a net change of -10 holders.
  • The largest BIO-key International seller in Q2 2026 was Geode Capital Management, an estimated $157K sold.

Based on aggregated 13F filings for Q2 2026.